gastrointestinal Archives -

Two weeks after reporting disappointing results for its lead coeliac disease therapy, 9 Meters Biopharma will draw some

After coeliac fail, 9 Meters plots phase 3 in short bowel syndrome

https://pharmaphorum.com/news/after-coeliac-fail-9-meters-plots-phase-3-in-short-bowel-syndrome/

Digital/ News/ News

Alimetry nabs FDA okay for gastric disorder-diagnosing wearable

Phil Taylor Alimetry, diagnosis, digital, digital health, Gastric Alimetry, gastrointestinal, wearable 0 Comment

New Zealand medical tech startup Alimetry has claimed an FDA approval for a wearable device that can be

Alimetry nabs FDA okay for gastric disorder-diagnosing wearable

https://pharmaphorum.com/news/alimetry-nabs-fda-okay-for-gastric-disorder-diagnosing-wearable/

Digital/ News/ News

Mahana raises $61m for IBS digital therapeutic

Phil Taylor digital, digital health, digital therapeutics, financing, gastrointestinal, irritable bowel syndrome, Mahana Therapeutics 0 Comment

Mahana Therapeutics has raised second-round financing of $61 million that will be used to launch what it says

Mahana raises $61m for IBS digital therapeutic

https://pharmaphorum.com/news/mahana-raises-61m-for-digital-therapeutic-for-ibs/

News/ News/ R&D

Crowded psoriasis market cuts Lilly’s mirikizumab ambitions

Phil Taylor Crohn's disease, dermatology, Eli Lilly, gastrointestinal, Immunology and inflammation, mirikizumab, psoriasis, ulcerative colitis 0 Comment

Eli Lilly has walked away from a major indication for its blockbuster hopeful mirikizumab, shelving plans to file

Crowded psoriasis market cuts Lilly’s mirikizumab ambitions

https://pharmaphorum.com/news/crowded-psoriasis-market-cuts-lillys-mirikizumab-ambitions/

Stock brokers looking at computer screens, trading online.

News

California’s AMT is latest biotech aiming to go public in pandemic IPO craze

Richard Staines Applied Molecular Transport, Biotech, gastrointestinal, inflammatory diseases, IPO, ulcerative colitis 0 Comment

California’s Applied Molecular Transport has become the latest biotech to go for an IPO during the pandemic, aiming

California’s AMT is latest biotech aiming to go public in pandemic IPO craze

https://pharmaphorum.com/news/californias-amt/

Janssen J&J Johnson and Johnson pharmaceutical companies

News/ News/ R&D

Janssen trials ultrasound-guided approach to treating Crohn’s

Richard Staines Crohn's, gastrointestinal, inflammatory diseases, Janssen, Takeda, UCB 0 Comment

In the highly competitive market for inflammatory diseases such as Crohn’s, pharma companies are looking for ways to

Janssen trials ultrasound-guided approach to treating Crohn’s

https://pharmaphorum.com/news/janssen-trials-ultrasound-guided-approach-to-treating-crohns/

News/ News/ R&D

Sosei Heptares bags another big partnership, this time with Takeda

Phil Taylor gastrointestinal, GPCR, Heptares, partnering, Sosei, Takeda 0 Comment

Japanese biotech Sosei’s buyout of the UK’s Heptares four years ago has rewarded it with a string of

Sosei Heptares bags another big partnership, this time with Takeda

https://pharmaphorum.com/news/sosei-heptares-bags-another-big-partnership-this-time-with-takeda/

News/ News/ R&D

Drugs could mimic gut bacteria benefits to treat diabetes

George Underwood Diabetes, gastrointestinal, gut bacteria, microbiome 0 Comment

It may be possible to design drugs that mimic the positive health benefits of gut bacteria to treat

Drugs could mimic gut bacteria benefits to treat diabetes

https://pharmaphorum.com/news/drugs-gut-bacteria-diabetes/

News/ News/ Oncology

AZ joins with Seres to research role of gut microbiome in cancer

Richard Staines AstraZeneca, cancer, cancer immunotherapy, gastrointestinal, Seres Therapeutics 0 Comment

AstraZeneca has announced an immuno-oncology collaboration with US biotech Seres Therapeutics, which will focus on increasing understanding of

AZ joins with Seres to research role of gut microbiome in cancer

https://pharmaphorum.com/news/az-joins-with-seres-to-research-role-of-gut-microbiome-in-cancer/

Trending

gastrointestinal

Login